PMID: 8613707Apr 1, 1996Paper

Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma

Journal of Leukocyte Biology
X ZhangW J Murphy

Abstract

The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can produce nitric oxide (NO) when stimulated with lipopolysaccharide (LPS), with or without co-stimulation by interferon-gamma (IFN-gamma). Studies included structural comparison of the promoters for human and mouse inducible NO synthase (iNOS) genes, transfection and assay of human and mouse iNOS promoter regions in response to LPS +/- IFN-gamma, and electrophoretic mobility shift assays of kappa B response elements. Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene. The importance of resolution of this controversy is that future research in this area should be directed toward the understanding of alternative mechanisms that can result in the successful production of NO.

Citations

Jul 1, 1997·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·M H HelfrichS H Ralston
Oct 8, 1998·Multiple Sclerosis : Clinical and Laboratory Research·G GiovannoniE J Thompson
Oct 28, 1998·Environmental Health Perspectives·F H Guo, S C Erzurum
May 18, 1999·Molecular and Chemical Neuropathology·D G Walker
Jun 6, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Weiling XuSerpil C Erzurum
Sep 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gary C ChanPhilip A Marsden
Mar 7, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ronan KapetanovicDavid A Hume
Dec 26, 2001·American Journal of Respiratory Cell and Molecular Biology·Louise E Donnelly, Peter J Barnes
Mar 13, 1999·Critical Care Medicine·S MehtaS Magder
Feb 22, 2012·Cellular and Molecular Life Sciences : CMLS·Sylvie ReveneauAlena Pance
Jun 29, 2000·American Journal of Respiratory Cell and Molecular Biology·A R O'Brien-LadnerL J Wesselius
Aug 26, 1998·Clinical and Experimental Immunology·K D KrönckeV Kolb-Bachofen
Dec 14, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E Galea, D L Feinstein
Mar 19, 2011·Current Opinion in Cardiology·Apurva V Shirodkar, Philip A Marsden
Oct 24, 2014·Frontiers in Immunology·Anita C Thomas, Joshua T Mattila
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·P C MelbyJ E Coe
Apr 2, 1999·Alimentary Pharmacology & Therapeutics·A Perner, J Rask-Madsen
May 29, 1998·American Journal of Respiratory and Critical Care Medicine·Y FujiiS N Hussain
Apr 26, 2008·Circulation Research·Charles C Matouk, Philip A Marsden
Apr 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Luis E PerezPeter C Melby
Aug 31, 2001·Microscopy Research and Technique·A K Cross, M N Woodroofe
Mar 7, 2006·Nitric Oxide : Biology and Chemistry·Carlo PergolaLidia Sautebin
Sep 23, 2006·Journal of Pharmacological and Toxicological Methods·Saule NaureckienePhilip G Jones

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.